Pro Share Advisors LLC Syndax Pharmaceuticals Inc Transaction History

Pro Share Advisors LLC

$36.7 Billion
Q1 2024

A detailed history of Pro Share Advisors LLC transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Pro Share Advisors LLC holds 20,112 shares of SNDX stock, worth $415,513. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,112

Previous 15,513 29.65%

Holding current value

$415,513

Previous $335,000 42.69%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$19.71 - $24.57 $90,646 - $112,997	4,599 Added 29.65%	20,112 $478,000
Q4 2023 Feb 14, 2024	BUY	$11.39 - $21.67 $27,461 - $52,246	2,411 Added 18.4%	15,513 $335,000
Q3 2023 Nov 13, 2023	BUY	$14.52 - $21.77 $1,161 - $1,741	80 Added 0.61%	13,102 $190,000
Q2 2023 Aug 10, 2023	BUY	$19.35 - $22.31 $23,142 - $26,682	1,196 Added 10.11%	13,022 $272,000
Q1 2023 May 11, 2023	SELL	$20.66 - $28.98 $20 - $28	-1 Reduced 0.01%	11,826 $249,000

Q4 2022 Feb 02, 2023	BUY	$20.64 - $26.24 $24,788 - $31,514	1,201 Added 11.3%	11,827 $300,000
Q3 2022 Nov 04, 2022	BUY	$18.51 - $24.79 $8,014 - $10,734	433 Added 4.25%	10,626 $255,000
Q2 2022 Aug 01, 2022	SELL	$13.64 - $19.48 $60,602 - $86,549	-4,443 Reduced 30.36%	10,193 $195,000
Q1 2022 May 10, 2022	SELL	$14.84 - $22.15 $31,891 - $47,600	-2,149 Reduced 12.8%	14,636 $254,000
Q4 2021 Feb 08, 2022	BUY	$15.23 - $22.47 $9,655 - $14,245	634 Added 3.93%	16,785 $367,000
Q3 2021 Nov 12, 2021	SELL	$13.87 - $19.8 $58,018 - $82,823	-4,183 Reduced 20.57%	16,151 $309,000
Q2 2021 Aug 13, 2021	BUY	$13.42 - $25.18 $73,514 - $137,936	5,478 Added 36.87%	20,334 $349,000
Q1 2021 May 14, 2021	BUY	$19.28 - $24.59 $49,761 - $63,466	2,581 Added 21.03%	14,856 $332,000
Q4 2020 Feb 09, 2021	BUY	$15.1 - $26.44 $185,352 - $324,551	12,275 New	12,275 $273,000
Q4 2018 Feb 14, 2019	SELL	$3.6 - $8.42 $40,464 - $94,640	-11,240 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$6.33 - $8.08 $6,944 - $8,863	-1,097 Reduced 8.89%	11,240 $91,000
Q2 2018 Aug 13, 2018	SELL	$6.93 - $14.63 $3,083 - $6,510	-445 Reduced 3.48%	12,337 $87,000
Q1 2018 May 14, 2018	SELL	$8.71 - $14.82 $18,334 - $31,196	-2,105 Reduced 14.14%	12,782 $182,000
Q4 2017 Feb 14, 2018	BUY	$7.8 - $12.94 $116,118 - $192,637	14,887	14,887 $130,000

Others Institutions Holding SNDX

# of Institutions

195

Shares Held

90M

Call Options Held

353K

Put Options Held

207K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $1.17B
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Syndax Pharmaceuticals Inc Transaction History